Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.
Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.
Serenity Wealth is your trusted partner in financial coaching, helping you build your future.
2025 Serenity Wealth. All rights reserved. Empowering futures, one plan at a time.
